Eco R1 Capital, LLC Scholar Rock Holding Corp Transaction History

Eco R1 Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$24.14 - $35.18 $198,141 - $288,757	-8,208 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$27.38 - $42.21 $224,735 - $346,459	8,208 New	8,208 $271,000
Q2 2019 Aug 14, 2019	SELL	$14.61 - $22.45 $4.95 Million - $7.6 Million	-338,668 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$14.24 - $22.28 $16.2 Million - $25.3 Million	-1,135,560 Reduced 77.03%	338,668 $6.36 Million
Q4 2018 Feb 14, 2019	SELL	$17.86 - $28.77 $16 Million - $25.7 Million	-893,150 Reduced 37.73%	1,474,228 $33.9 Million
Q3 2018 Nov 14, 2018	SELL	$13.39 - $26.25 $4.07 Million - $7.97 Million	-303,783 Reduced 11.37%	2,367,378 $61 Million
Q2 2018 Aug 14, 2018	BUY	$15.0 - $25.6 $40.1 Million - $68.4 Million	2,671,161 New	2,671,161 $41.7 Million

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.31B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.